Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
From Clinical Care Options (CCO), Webcast and downloadable slides reviewing the latest data on the use of PARP inhibitors to treat newly diagnosed advanced ovarian cancer
On-demand Clinical Care Options (CCO) Webcast that reviews the latest clinical data informing the optimal management of patients with ovarian cancer from an expert global perspective.
Expert commentary on the use of PARP inhibitors as frontline maintenance therapy in the treatment of ovarian cancer, from Clinical Care Options
In this slideset, CCO’s expert faculty explores the role of biomarkers and HRD when treating patients with ovarian cancer using PARP inhibitors
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.